Tag Archives: Prostate cancer
FDA to Review Prostate Cancer Meds
Image via Wikipedia
FDA, on Monday, announced that it was reviewing whether a certain class of prostate cancer drugs could lead to diabetes, stroke, death, or heart problems.
The drugs in question are gonadotropin-Releasing Hormone (GnRH) agonists, marketed under a number of monikers, including Vantas and Lupron. These treatments are used to slow the growth of prostate [...]
Posted in FDA, Safety Also tagged Cancer, Conditions and Diseases, Diabetes mellitus, Food and Drug Administration, Genitourinary, Health, Heart disease Leave a comment
Takeda Changes Dexlansoprazole Brand Name From Kapidex to Dexilant
Takeda’s US subsidiary launched its proton pump inhibitor dexlansoprazole last February under the name Kapidex. No one thought they’d have to find a new name a year later.
But shortly after the launch, the company began getting reports of dispensing errors. Some were due to prescription misreading, others to simple, honest mistakes. The two drugs causing [...]
Posted in Corporate Responsibility, FDA, Marketing, News, Safety, Strategy Also tagged Casodex, chronic pain, Dexilant, dexlansoprazole, dispensing error, FDA, Kadian, Kapidex, proton pump inhibitor, Takeda 2 Comments
Dendreon Picks Bishop as COO
Congratulations are in order for Hans Bishop, one of our 2009 emerging leaders. Dendreon just announced that it appointed Bishop chief operating officer in charge of the pending launch of the prostate cancer treatment Provenge.
“Hans’ extensive and successful global commercial experience will add tremendous value to Dendreon’s already strong executive team as we prepare for [...]
Posted in People Also tagged Bayer, business, Cancer, Conditions and Diseases, Dendreon, Hans Bishop, Health, Sipuleucel-T Leave a comment

Pfizer Ends Sutent Trial